Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling
Xinlei Liu, Yan Zhang, Chunya Ma, Juntang Lin, Jiang Du
Topics & Concepts
FGF21Fatty liverEndocrinologyInternal medicineNonalcoholic fatty liver diseaseLipogenesisSteatosisLipid metabolismCirrhosisIntermittent fastingMedicineBiologyFibroblast growth factorDiseaseReceptorDietary Effects on HealthFibroblast Growth Factor ResearchLiver Disease Diagnosis and Treatment